Selective modulation of intracellular effects of cells using pulsed electric fields
A system and method for selectively treating aberrant cells such as cancer cells through administration of a train of electrical pulses is described. The pulse length and delay between successive pulses is optimized to produce effects on intracellular membrane potentials. Therapies based on the system and method produce two treatment zones: an ablation zone surrounding the electrodes within which aberrant cells are non-selectively killed and a selective treatment zone surrounding the ablation zone within which target cells are selectively killed through effects on intracellular membrane potentials. As a result, infiltrating tumor cells within a tumor margin can be effectively treated while sparing healthy tissue. The system and method are useful for treating various cancers in which solid tumors form and have a chance of recurrence from microscopic disease surrounding the tumor.
1 . A non-thermal ablation system comprising:
at least one electrode;
a voltage pulse generator operatively coupled to the at least one electrode and configured to apply a plurality of electrical pulses to a target region, wherein the plurality of pulses is configured to produce a first treatment zone and a second treatment zone;
wherein only selected cells are affected by the plurality of electrical pulses in the second treatment zone; and
wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that non-thermal ablation occurs in the first treatment zone.
2 . The system of claim 1 , wherein the voltage pulse generator is configured to apply a plurality of electrical pulses such that:
at least one cancer cell and at least one non-cancer cell are killed in the first treatment zone; or
at least one cancer cell is killed or inhibited, and at least one non-cancer cell are spared, in the second treatment zone.
3 . The system of claim 1 , wherein irreversible electroporation occurs in the first treatment zone.
4 . The system of claim 1 , wherein the plurality of electrical pulses comprises an electric field waveform which is unipolar or bipolar.
5 . The system of claim 1 , wherein the target region includes pancreas tissue, prostate tissue, liver tissue, or kidney tissue.
6 . The system of claim 1 , wherein at least one pulse parameter relative to the plurality of electrical pulses is configured to produce the first treatment zone and the second treatment zone.
7 . The system of claim 6 , wherein the at least one pulse parameter includes a length of each pulse of the plurality of electrical pulses.
8 . The system of claim 6 , wherein the at least one pulse parameter includes a delay between the successive pulses.
9 . The system of claim 1 , wherein the selected cells are cancer cells, infiltrative cells, undesired cells, healthy cells, normal cells, and/or non-cancer cells.
10 . The system of claim 1 , wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that:
some cells are killed by necrosis; or
some cells are killed by apoptosis; or
some cells are killed by necrosis and some cells are killed by apoptosis.
11 . The system of claim 1 , wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that:
within the first treatment zone cells are affected on the order of minutes; and
within the second treatment zone cells are affected on the order of hours.
12 . The system of claim 1 , wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that a delay between successive pulses is greater than a length of each pulse.
13 . The system of claim 1 , wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that irreversible electroporation occurs in the first treatment zone.
14 . The system of claim 1 , wherein the selected cells are cancer cells which are inhibited:
by way of slowed or arrested cell division, or
by way of slowed or arrested migration, or
by way of reduced transport of blood and nutrients.
15 . A non-thermal ablation system comprising:
at least one electrode;
a voltage pulse generator operatively coupled to the at least one electrode and configured to apply a plurality of electrical pulses to a target region with a delay between successive pulses, wherein at least one pulse parameter relative to the plurality of pulses is optimized to produce a first treatment zone and a second treatment zone;
wherein only selected cells are affected by the plurality of electrical pulses in the second treatment zone; and
wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that non-thermal ablation occurs in the first treatment zone.
16 . The system of claim 15 , wherein irreversible electroporation occurs in the first treatment zone.
17 . The system of claim 15 , wherein the plurality of electrical pulses comprises an electric field waveform which is biphasic or monophasic.
18 . The system of claim 15 , wherein the at least one pulse parameter includes a length of each pulse and the delay between successive pulses.
19 . The system of claim 18 , wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that the delay between successive pulses is greater than the length of each pulse.
20 . A non-thermal ablation system comprising:
two or more electrodes;
a voltage pulse generator operatively coupled to the two or more electrodes and configured to apply a plurality of electrical pulses to a target region with a delay between successive pulses, wherein the plurality of pulses is configured to produce a first treatment zone and a second treatment zone;
wherein only selected cells are affected by the plurality of electrical pulses in the second treatment zone; and
wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that non-thermal ablation occurs in the first treatment zone.